{"id":"W2005204505","doi":"10.1177/1078155214533367","title":"Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3 mL per injection site","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Tolerability; Dosing; Subcutaneous injection; Anesthesia; Route of administration; Multiple myeloma; Adverse effect; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001757154,0.000130471,0.0005652233,0.0002110031,0.00005890152,0.0000095435,0.00009005149,0.00009932515,0.0002628737],"category_scores_gemma":[0.002727648,0.0001096765,0.0001665709,0.0001723949,0.0001317596,0.0005138823,0.00003061443,0.000578736,0.000009473978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003797658,"about_ca_system_score_gemma":0.001091958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002011044,"about_ca_topic_score_gemma":0.00001332084,"domain_scores_codex":[0.9975208,0.0006882121,0.0009106462,0.0001540563,0.0005121377,0.0002141619],"domain_scores_gemma":[0.9959391,0.0008901718,0.001589234,0.0001770722,0.001181848,0.0002225884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0823749,0.00930896,0.2518052,0.0005470858,0.001838265,0.002088916,0.001523924,0.0006015452,0.5068638,0.0000223272,0.0008197514,0.1422053],"study_design_scores_gemma":[0.06805747,0.07901666,0.1733832,0.0004807159,0.008452006,0.1604397,0.002018363,0.04924692,0.1824394,0.000410361,0.275384,0.0006711584],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938003,0.000149078,0.001205744,0.002567319,0.0002922405,0.0002882859,0.0000105301,0.000006403717,0.00168004],"genre_scores_gemma":[0.9887007,0.0001453205,0.01057951,0.000190078,0.0002831014,0.000002297454,0.000006240772,0.00001435791,0.00007832967],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3244243,"threshold_uncertainty_score":0.4472476,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0622537412032568,"score_gpt":0.4347714572492852,"score_spread":0.3725177160460283,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}